Clinical Trial Update: PROACT - Pre-Operative Arimidex Compared To Tamoxifen [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing preoperative use of anastrozole (Arimidex) to tamoxifen in breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED